NCT07136935

Brief Summary

Exploring the Impact and Effectiveness of an Integrated Traditional Chinese and Western Medicine Treatment Model in Post-Acute Care for Frail Older Patients.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
11mo left

Started Jul 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress46%
Jul 2025Mar 2027

Study Start

First participant enrolled

July 28, 2025

Completed
17 days until next milestone

First Submitted

Initial submission to the registry

August 14, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

August 22, 2025

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2027

Last Updated

August 22, 2025

Status Verified

August 1, 2025

Enrollment Period

1.4 years

First QC Date

August 14, 2025

Last Update Submit

August 21, 2025

Conditions

Keywords

frailtyChinese and Western Integrated medicine

Outcome Measures

Primary Outcomes (3)

  • Study of Osteoporotic Fractures

    Measured by the Study of Osteoporotic Fractures (SOF Index) ,score of 0\~2 : 0=robust,1 =prefrail,2= frail.

    At baseline, End of treatment(4 weeks)

  • comprehensive geriatric assessment

    Measured by comprehensive geriatric assessment(CGA)

    At baseline, End of treatment(4 weeks)

  • Body Constitution Questionnaire / Constitution in Chinese Medicine Questionnaire

    Measured by Body Constitution Questionnaire(BCQ) / Constitution in Chinese Medicine Questionnaire(CCMQ)

    At baseline, End of treatment(4 weeks)

Secondary Outcomes (5)

  • Height

    At baseline, End of treatment(4 weeks)

  • Weight

    At baseline, End of treatment(4 weeks)

  • Calf circumference

    At baseline, End of treatment(4 weeks)

  • Grip strength

    At baseline, End of treatment(4 weeks)

  • Gait speed

    At baseline, End of treatment(4 weeks)

Study Arms (1)

intervention group

EXPERIMENTAL

1. Oral Chinese herbal medicine or decoction 2. Acupuncture or laser acupuncture treatment 3. Acupoint massage 4. Traditional Chinese Medicine Cake Acupoint Application 5. Nursing and health education and guidance 6. Dietary hygiene education 7. Lifestyle health education and sports rehabilitation

Drug: Traditional Chinese Medicine treatment

Interventions

1. Oral Chinese herbal medicine or decoction: prescribe Chinese medicine based on syndrome differentiation and treatment of the patient's condition. 2. Acupuncture or laser acupuncture treatment: Traditional Chinese medicine practitioners select acupuncture points to treat based on the patient's condition, and treat them once a week. 3. Acupoint massage: Select treatment acupoints and techniques according to the patient's condition, 20 minutes at a time. 4. Traditional Chinese Medicine Cake Acupoint Application: Warm Navel Cream to the CV-4 (Guanyuan) acupoint, the application time is 2 to 4 hours. 5. Nursing and health education and guidance. 6. Dietary hygiene education: personalized western nutrition and TCM dietary guidance suggestions based on TCM constitution syndromes. 7. Lifestyle health education and sports rehabilitation: Playing Baduanjin, ten skilled hand exercise, and health preservation videos, and providing personalized TCM exercise recommendations.

intervention group

Eligibility Criteria

Age20 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Elderly patients aged ≥75 years.
  • A history of at least one of the following conditions: Parkinson's disease, chronic obstructive pulmonary disease (COPD), mild dementia, or chronic kidney disease at stage 3 or above.
  • Hospitalized due to an acute illness (length of hospital stay \>72 hours).
  • Functional decline within one month after completion of treatment.
  • Clinical Frailty Scale (CFS) score of 5-7 (indicating moderate or greater frailty, with retained rehabilitation potential).
  • Can answer clinical questionnaires and scales.

You may not qualify if:

  • Medically unstable (requiring intensive medical interventions, diagnostic testing, or supplemental oxygen).
  • Unable to cooperate with treatment or communication.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

China Medical University Hospital

Taichung, 403, Taiwan

RECRUITING

MeSH Terms

Conditions

Frailty

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 14, 2025

First Posted

August 22, 2025

Study Start

July 28, 2025

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

March 31, 2027

Last Updated

August 22, 2025

Record last verified: 2025-08

Locations